Table 1 Patient and Tumor Characteristics (n: 116).
From: Prognostic impact of CD133 expression in Endometrial Cancer Patients
Condition, n(%) | |||
|---|---|---|---|
Menopause | No 27 (23.8%) | Yes (89, 76.2%) | |
Parity | No (19, 19.6%) | 1: (21, 21.6%) | >1: 57, (58.7%) |
EEC Grade | 1 79 (68.1%) | 2: 24 (20.7%) | 3: 13 (11.2%) |
FIGO Stage | I (96 (82.8%) | II: 11 (9.5%) | III: 9 (7.8%) |
Myometrial infiltration | No: 5 (4.3%) | <50%: 53 (45.7%) | >50%: 57 (49.1%) |
Vascular invasion | No: 103 (88.8%) | Yes: 13 (11.2%) | |
Peritumoral inflammation | No: 34 (29.6%) | Yes: 81 (70.4%) | |
Leucocytes infiltration | No: 75 (65.2%) | Yes: 40 (34.8%) | |
